Table 1.

Characteristics of the study population

CharacteristicHU-naïve patients (n = 23)HU-exposed patients (n = 15)P*
No. (%)Median (range)Percentage of patients with abnormal valuesNo. (%)Median (range)Percentage of patients with abnormal values
Acute chest syndrome (episodesin the year preceding thesemen analysis)  1.0 (0-5)   3 (0-14.0)  .0330 
Hospitalizations for vaso-occlusive events (in the year preceding the semen analysis)  1.0 (0-7.0)   1.5 (0-5.0)  .7305 
Age at the time of the semen analysis, y  20 (16-24)   17 (16-23)  .0048 
Treatment        
 Age at HU initiation, y  —   6.0 (1.0-14.0)   
 Duration of HU treatment before the semen analysis, y  —   4.0 (0.5-10.0)   
 Wash-out period, y  —   2.5 (0-13.0)   
 In a transfusion program at the time of the semen analysis,n (%) 12 (52)   15 (100)   .0052 
 Transfusion program duration before the semenanalysis, y  0 (0-8.0)   3 (0-13.0)  .0228 
Indication for HU        
 Acute chest syndrome orvaso-occlusive events —      
 Vasculopathy —      
 Anemia —      
Indication for transfusion 12 (52)   15 (100)    
 Vasculopathy      
 Recurrent acute chestsyndrome/vaso-occlusive event      
 Sperm banking      
 Anemia —      
Sperm parameters        
 Semen volume (mL) 46 2.0 (0.25-5.90) 36.96 26 2.7 (0.20-10.35) 26.92 .5265 
 Sperm concentration (106/mL) 46 8.0 (0.00-120.00) 56.52 26 25.3 (0.00-210.00) 50.00 .3952 
 Total sperm count (×10645 12.0 (0.00-523.90) 64.44 22 77.5 (0.40-525.00) 40.91 .0625 
 Progressive motility (% of spermatozoa) 46 35.0 (1.00-55.00) 45.65 26 32.0 (0.00-75.00) 50.00 .4541 
 Typical forms (% of spermatozoa) 25 9.5 (0.00-38.00) 88.00 16 6.0 (0.00-25.00) 93.75 .2081 
 Vitality (% of live spermatozoa) 39 58.0 (0.00-87.00) 48.72 22 52.5 (12.00-77.00) 59.09 .4396 
 Sexual abstinence, d 28 5.0 (2.00-30.00) 14.29 24 6.0 (2.00-90.00) 33.33 .1860 
CharacteristicHU-naïve patients (n = 23)HU-exposed patients (n = 15)P*
No. (%)Median (range)Percentage of patients with abnormal valuesNo. (%)Median (range)Percentage of patients with abnormal values
Acute chest syndrome (episodesin the year preceding thesemen analysis)  1.0 (0-5)   3 (0-14.0)  .0330 
Hospitalizations for vaso-occlusive events (in the year preceding the semen analysis)  1.0 (0-7.0)   1.5 (0-5.0)  .7305 
Age at the time of the semen analysis, y  20 (16-24)   17 (16-23)  .0048 
Treatment        
 Age at HU initiation, y  —   6.0 (1.0-14.0)   
 Duration of HU treatment before the semen analysis, y  —   4.0 (0.5-10.0)   
 Wash-out period, y  —   2.5 (0-13.0)   
 In a transfusion program at the time of the semen analysis,n (%) 12 (52)   15 (100)   .0052 
 Transfusion program duration before the semenanalysis, y  0 (0-8.0)   3 (0-13.0)  .0228 
Indication for HU        
 Acute chest syndrome orvaso-occlusive events —      
 Vasculopathy —      
 Anemia —      
Indication for transfusion 12 (52)   15 (100)    
 Vasculopathy      
 Recurrent acute chestsyndrome/vaso-occlusive event      
 Sperm banking      
 Anemia —      
Sperm parameters        
 Semen volume (mL) 46 2.0 (0.25-5.90) 36.96 26 2.7 (0.20-10.35) 26.92 .5265 
 Sperm concentration (106/mL) 46 8.0 (0.00-120.00) 56.52 26 25.3 (0.00-210.00) 50.00 .3952 
 Total sperm count (×10645 12.0 (0.00-523.90) 64.44 22 77.5 (0.40-525.00) 40.91 .0625 
 Progressive motility (% of spermatozoa) 46 35.0 (1.00-55.00) 45.65 26 32.0 (0.00-75.00) 50.00 .4541 
 Typical forms (% of spermatozoa) 25 9.5 (0.00-38.00) 88.00 16 6.0 (0.00-25.00) 93.75 .2081 
 Vitality (% of live spermatozoa) 39 58.0 (0.00-87.00) 48.72 22 52.5 (12.00-77.00) 59.09 .4396 
 Sexual abstinence, d 28 5.0 (2.00-30.00) 14.29 24 6.0 (2.00-90.00) 33.33 .1860 
*

Mann-Whitney U test.

Close Modal

or Create an Account

Close Modal
Close Modal